Avricore Health (AVCRF) EBITDA Margin (2009 - 2026)
Avricore Health (AVCRF) posted quarterly EBITDA Margin of 546.08% for Q2 2026, up 110589.0% year-over-year from N/an in Q2 2025, and up 59.59% quarter-over-quarter from 1351.21% in Q4 2025.
Avricore Health (AVCRF) EBITDA Margin (2009 - 2026) Analysis & Trends
Avricore Health (AVCRF) has reported EBITDA Margin for 17 consecutive years, with 546.08% the latest figure, recorded in Q2 2026.
- In Q2 2026, EBITDA Margin rose 110589.0% year-over-year to 546.08%; the TTM figure through Jun 2026 stood at 1074.26% (down 106591.0% YoY), while the FY2025 annual figure was 259.13%, down 26183.0% from the prior year.
- EBITDA Margin rose to 546.08% in Q2 2026 per AVCRF's latest filing, from 1351.21% in the prior quarter.
- Across five years, EBITDA Margin topped out at 16.9% in Q1 2023 and bottomed at 1651.97% in Q2 2025.
- Historically, EBITDA Margin has averaged 304.69% across 5 years, with a median of 30.96% in 2022.
- Annual changes were most pronounced in 2025 — EBITDA Margin plunged 166177 bps — and 2026, when it surged 110589 bps.
- Avricore Health's EBITDA Margin stood at 24.43% in 2022, then jumped by 121 bps to 5.07% in 2023, then sank by 203 bps to 5.2% in 2024, then tumbled by 25880 bps to 1351.21% in 2025, then jumped by 60 bps to 546.08% in 2026.
- Business Quant data shows AVCRF's EBITDA Margin at 546.08% in Q2 2026, 1351.21% in Q4 2025, and 1012.72% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 17.40% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.99% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.98% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 21.74% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 11.58% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -13.42% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 21.14% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 31.97% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 15.08% |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 | -546.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -546.08% |
| Dec 31, 2025 | -1,351.21% |
| Sep 30, 2025 | -1,012.72% |
| Jun 30, 2025 | -1,651.97% |
| Mar 31, 2025 | -17.48% |
| Sep 30, 2024 | -5.20% |
| Jun 30, 2024 | 9.80% |
| Mar 31, 2024 | 14.10% |
| Dec 31, 2023 | 5.07% |
| Sep 30, 2023 | -29.84% |
| Jun 30, 2023 | -51.85% |
| Mar 31, 2023 | 16.90% |
| Dec 31, 2022 | -24.43% |
| Sep 30, 2022 | -32.07% |
| Jun 30, 2022 | -119.12% |
| Mar 31, 2022 | -78.92% |
| Dec 31, 2021 | -161.24% |
| Sep 30, 2021 | -42.97% |
| Jun 30, 2021 | -991.11% |
| Mar 31, 2021 | -659.25% |